BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 19169115)

  • 1. The Indiana Chronic Disease Management Program's impact on medicaid claims: a longitudinal, statewide evaluation.
    Katz BP; Holmes AM; Stump TE; Downs SM; Zillich AJ; Ackermann RT; Inui TS
    Med Care; 2009 Feb; 47(2):154-60. PubMed ID: 19169115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The net fiscal impact of a chronic disease management program: Indiana Medicaid.
    Holmes AM; Ackermann RD; Zillich AJ; Katz BP; Downs SM; Inui TS
    Health Aff (Millwood); 2008; 27(3):855-64. PubMed ID: 18474980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utilization of, and adherence to, drug therapy among medicaid beneficiaries with congestive heart failure.
    Bagchi AD; Esposito D; Kim M; Verdier J; Bencio D
    Clin Ther; 2007 Aug; 29(8):1771-83. PubMed ID: 17919558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The structure and content of telephonic scripts found useful in a Medicaid Chronic Disease Management Program.
    Roth AM; Ackermann RT; Downs SM; Downs AM; Zillich AJ; Holmes AM; Katz BP; Murray MD; Inui TS
    Chronic Illn; 2010 Jun; 6(2):83-8. PubMed ID: 20484324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Indiana Chronic Disease Management Program.
    Rosenman MB; Holmes AM; Ackermann RT; Murray MD; Doebbeling CC; Katz B; Li J; Zillich A; Prescott VM; Downs SM; Inui TS
    Milbank Q; 2006; 84(1):135-63. PubMed ID: 16529571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of disease management on health care utilization: evidence from the "Florida: A Healthy State (FAHS)" Medicaid Program.
    Afifi AA; Morisky DE; Kominski GF; Kotlerman JB
    Prev Med; 2007 Jun; 44(6):547-53. PubMed ID: 17350086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of a Medicaid copayment policy on prescription drug and health services utilization in a fee-for-service Medicaid population.
    Hartung DM; Carlson MJ; Kraemer DF; Haxby DG; Ketchum KL; Greenlick MR
    Med Care; 2008 Jun; 46(6):565-72. PubMed ID: 18520310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lapses in Medicaid coverage: impact on cost and utilization among individuals with diabetes enrolled in Medicaid.
    Hall AG; Harman JS; Zhang J
    Med Care; 2008 Dec; 46(12):1219-25. PubMed ID: 19300311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utilization and costs of medical services and prescription medications for rheumatoid arthritis among recipients covered by a state Medicaid program: a retrospective, cross-sectional, descriptive, database analysis.
    Khanna R; Smith MJ
    Clin Ther; 2007 Nov; 29(11):2456-67. PubMed ID: 18158087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing multiple hospitalizations for health-plan-managed Medicaid diabetic members.
    Cramer S; Chapa G; Kotsos T; Jenich H
    J Healthc Qual; 2010; 32(3):7-14. PubMed ID: 20500775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing the costs of chronic obstructive pulmonary disease: the state medicaid perspective.
    Marton JP; Boulanger L; Friedman M; Dixon D; Wilson J; Menzin J
    Respir Med; 2006 Jun; 100(6):996-1005. PubMed ID: 16288858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Telephonic case-finding of major depression in a Medicaid chronic disease management program for diabetes and heart failure.
    Ackermann RT; Rosenman MB; Downs SM; Holmes AM; Katz BP; Li J; Zillich AJ; Carney CP; Inui TS
    Gen Hosp Psychiatry; 2005; 27(5):338-43. PubMed ID: 16168794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disease management 360 degrees: a scorecard approach to evaluating TRICARE's programs for asthma, congestive heart failure, and diabetes.
    Yang W; Dall TM; Zhang Y; Hogan PF; Arday DR; Gantt CJ
    Med Care; 2010 Aug; 48(8):683-93. PubMed ID: 20613658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Examining costs of chronic conditions in a Medicaid population.
    Garis RI; Farmer KC
    Manag Care; 2002 Aug; 11(8):43-50. PubMed ID: 12232928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes and lessons learned from evaluating TRICARE's disease management programs.
    Dall TM; Askarinam Wagner RC; Zhang Y; Yang W; Arday DR; Gantt CJ
    Am J Manag Care; 2010 Jun; 16(6):438-46. PubMed ID: 20560687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prenatal syphilis screening rates measured using medicaid claims and electronic medical records.
    Rosenman MB; Tao G; Szucs KA; Wang J; Ambuehl R; Mahon BE
    Sex Transm Dis; 2008 Apr; 35(4):387-92. PubMed ID: 18362860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using predictive modeling to evaluate the financial effect of disease management.
    Whitlock T; Johnston K
    Manag Care Interface; 2006 Sep; 19(9):29-34, 46. PubMed ID: 17017310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of chronic disease management on outcomes and cost of care for Medicaid beneficiaries.
    Zhang NJ; Wan TT; Rossiter LF; Murawski MM; Patel UB
    Health Policy; 2008 May; 86(2-3):345-54. PubMed ID: 18207282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Good and poor adherence: optimal cut-point for adherence measures using administrative claims data.
    Karve S; Cleves MA; Helm M; Hudson TJ; West DS; Martin BC
    Curr Med Res Opin; 2009 Sep; 25(9):2303-10. PubMed ID: 19635045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fragmentation of care for frequently hospitalized urban residents.
    Schrag D; Xu F; Hanger M; Elkin E; Bickell NA; Bach PB
    Med Care; 2006 Jun; 44(6):560-7. PubMed ID: 16708005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.